Fnu G, Weber G
Oncotarget. 2023; 14:957-969.
PMID: 38039408
PMC: 10691814.
DOI: 10.18632/oncotarget.28540.
Zeng B, Chen Y, Chen H, Zhao Q, Sun Z, Liu D
Mol Oncol. 2023; 17(12):2743-2766.
PMID: 37356089
PMC: 10701767.
DOI: 10.1002/1878-0261.13480.
Khan I, Gril B, Hoshino A, Yang H, Lee M, Difilippantonio S
Clin Exp Metastasis. 2022; 39(5):815-831.
PMID: 35939247
PMC: 10642714.
DOI: 10.1007/s10585-022-10182-7.
Sinha S, Singh S, Jangde N, Ray R, Rai V
Cell Death Dis. 2021; 12(11):1012.
PMID: 34711805
PMC: 8553772.
DOI: 10.1038/s41419-021-04311-5.
Bonitto E, McKeown B, Goralski K
Pharmacol Res Perspect. 2021; 9(6):e00886.
PMID: 34708587
PMC: 8551564.
DOI: 10.1002/prp2.886.
Evaluation of Computationally Designed Peptides against TWEAK, a Cytokine of the Tumour Necrosis Factor Ligand Family.
Badia-Villanueva M, Defaus S, Foj R, Andreu D, Oliva B, Sierra A
Int J Mol Sci. 2021; 22(3).
PMID: 33494438
PMC: 7866087.
DOI: 10.3390/ijms22031066.
Evaluation genotypes of cancer cell lines HCC1954 and SiHa by short tandem repeat (STR) analysis and DNA sequencing.
Fu J, Cheng J, Liu X, Li J, Wei C, Zheng X
Mol Biol Rep. 2018; 45(6):2689-2695.
PMID: 30390187
DOI: 10.1007/s11033-018-4438-7.
Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8.
Tudrej P, Olbryt M, Zembala-Nozynska E, Kujawa K, Cortez A, Fiszer-Kierzkowska A
Int J Mol Sci. 2018; 19(7).
PMID: 30018258
PMC: 6073376.
DOI: 10.3390/ijms19072080.
B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer.
Wang L, Yang C, Liu X, Wang L, Kang F
Cancer Cell Int. 2018; 18:100.
PMID: 30008617
PMC: 6044050.
DOI: 10.1186/s12935-018-0597-9.
Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxins.
Eng M, Kaur J, Prasmickaite L, Engesaeter B, Weyergang A, Skarpen E
Photochem Photobiol Sci. 2018; 17(5):539-551.
PMID: 29565434
PMC: 8728892.
DOI: 10.1039/C7PP00358G.
Metabolomics guided pathway analysis reveals link between cancer metastasis, cholesterol sulfate, and phospholipids.
Johnson C, Santidrian A, LeBoeuf S, Kurczy M, Rattray N, Rattray Z
Cancer Metab. 2017; 5:9.
PMID: 29093815
PMC: 5663111.
DOI: 10.1186/s40170-017-0171-2.
Application of a co‑expression network for the analysis of aggressive and non‑aggressive breast cancer cell lines to predict the clinical outcome of patients.
Guo L, Zhang K, Bing Z
Mol Med Rep. 2017; 16(6):7967-7978.
PMID: 28944917
PMC: 5779881.
DOI: 10.3892/mmr.2017.7608.
Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line.
Korch C, Hall E, Dirks W, Ewing M, Faries M, Varella-Garcia M
Int J Cancer. 2017; 142(3):561-572.
PMID: 28940260
PMC: 5762610.
DOI: 10.1002/ijc.31067.
Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment.
Heerma van Voss M, Vesuna F, Bol G, Afzal J, Tantravedi S, Bergman Y
Oncogene. 2017; 37(1):63-74.
PMID: 28869602
PMC: 5756132.
DOI: 10.1038/onc.2017.308.
Continued use of MDA-MB-435, a melanoma cell line, as a model for human breast cancer, even in year, 2014.
Prasad V, Gopalan R
NPJ Breast Cancer. 2017; 1:15002.
PMID: 28721362
PMC: 5515196.
DOI: 10.1038/npjbcancer.2015.2.
Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.
McConnell M, Feng S, Chen W, Zhu G, Shen D, Ponnazhagan S
Oncotarget. 2017; 8(29):47675-47690.
PMID: 28504970
PMC: 5564597.
DOI: 10.18632/oncotarget.17544.
Histone deacetylase activity mediates acquired resistance towards structurally diverse HSP90 inhibitors.
Chai R, Vieusseux J, Lang B, Nguyen C, Kouspou M, Britt K
Mol Oncol. 2017; 11(5):567-583.
PMID: 28306192
PMC: 5527463.
DOI: 10.1002/1878-0261.12054.
Organ-specific isogenic metastatic breast cancer cell lines exhibit distinct Raman spectral signatures and metabolomes.
Winnard Jr P, Zhang C, Vesuna F, Kang J, Garry J, Dasari R
Oncotarget. 2017; 8(12):20266-20287.
PMID: 28145887
PMC: 5386761.
DOI: 10.18632/oncotarget.14865.
Ghrelin and Breast Cancer: Emerging Roles in Obesity, Estrogen Regulation, and Cancer.
Au C, Furness J, Brown K
Front Oncol. 2017; 6:265.
PMID: 28119851
PMC: 5220482.
DOI: 10.3389/fonc.2016.00265.
In Vivo Electrical Conductivity Contrast Imaging in a Mouse Model of Cancer Using High-Frequency Magnetoacoustic Tomography With Magnetic Induction (hfMAT-MI).
Yu K, Shao Q, Ashkenazi S, Bischof J, He B
IEEE Trans Med Imaging. 2016; 35(10):2301-2311.
PMID: 27834641
PMC: 7941609.
DOI: 10.1109/TMI.2016.2560146.